MDCX · ISSUER CIK 1997296
Medicus Pharma Ltd.
Between Aug 1, 2026 and Oct 29, 2026, 5 Medicus Pharma Ltd. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202617:02 | Sep 4, 2026 | MDCX | Chief Operating Officer | A · Grant | $0.17 | +735,294 | 735,458 | +448350% | $125K | ||
| Sep 8, 202617:01 | Sep 4, 2026 | MDCX | Chief Medical Officer | A · Grant | $0.17 | +1,470,588 | 1,470,588 | New | $251K | ||
| Sep 8, 202617:01 | Sep 4, 2026 | MDCX | Chief Scientific Officer | A · Grant | $0.17 | +588,235 | 674,735 | +680% | $100K | ||
| Sep 8, 202617:00 | Sep 4, 2026 | MDCX | President and CFO | A · Grant | $0.17 | +1,470,588 | 1,489,493 | +7779% | $251K | ||
| Sep 8, 202617:00 | Sep 4, 2026 | MDCX | Chief Executive Officer, Director | A · Grant | $0.17 | +2,941,176 | 2,941,176 | New | $501K |